Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

Fouad Shalaby, Janet Rossant, Terry P. Yamaguchi et al. · Nature · 1995 · 3.9K citations

Medicine, Cell Biology, Pathology +8

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

Harold F. Dvorak, Lawrence F. Brown, Michael Detmar et al. · PubMed · 1995 · 3.1K citations

Veterinary Medicine, Physiology, Tumor Microenvironment +9

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry et al. · New England Journal of Medicine · 2003 · 2.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

The <i>fms</i> -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor

Carlie de Vries, Jaime A. Escobedo, Hikaru Ueno et al. · Science · 1992 · 2K citations

Life Sciences, Cell Biology, Molecular Biology +14

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso et al. · Cancer Cell · 2007 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +17